Subscribe to our News Updates & Alerts

ASX AGN: A$

Home
About
Investors
Technology
Media
- News & Media
Contact

Financial Reports

Coming Soon

2025
2024
2023
2022
2021

30 Apr 2025Quarterly Activities/Appendix 4C Cash Flow Report
11 Feb 2025Half Yearly Report and Accounts
30 Jan 2025Quarterly Activities/Appendix 4C Cash Flow Report

31 Oct 2024Quarterly Activities/Appendix 4C Cash Flow Report - updated
31 Oct 2024Quarterly Activities/Appendix 4C Cash Flow Report
28 Aug 2024Appendix 4E & Annual Report to 30 June 2024
31 Jul 2024Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 2024Quarterly Activities/Appendix 4C Cash Flow Report
28 Feb 2024Half Yearly Report and Accounts
31 Jan 2024Quarterly Activities/Appendix 4C Cash Flow Report

26 Oct 2023Quarterly Activities/Appendix 4C Cash Flow Report
23 Aug 2023Appendix 4E & Annual Report 30 June 2023
24 Jul 2023Quarterly Activities/Appendix 4C Cash Flow Report
27 Apr 2023Quarterly Activities/Appendix 4C Cash Flow Report
28 Feb 2023Half Yearly Report and Accounts
31 Jan 2023Quarterly Activities/Appendix 4C Cash Flow Report

31 Oct 2022Quarterly Activities/Appendix 4C Cash Flow Report
23 Aug 2022Appendix 4E & Annual Report 30 June 2022
29 Jul 2022Quarterly Activities/Appendix 4C Cash Flow Report
29 Apr 2022Quarterly Activities/Appendix 4C Cash Flow Report
22 Feb 2022Half Yearly Report and Accounts
27 Jan 2022Quarterly Activities/Appendix 4C Cash Flow Report

28 Oct 2021Quarterly Activities/Appendix 4C Cash Flow Report
27 Aug 2021Appendix 4E & Annual Report 30 June 2021
29 Jul 2021Quarterly Activities/Appendix 4C Cash Flow Report

Subscribe to our mailing list to stay up to date with Argenica Therapeutics

Argenica Therapeutics Limited
4/117 Broadway
Nedlands WA 6009, Australia
PO Box 1458, West Perth WA 6872

Ph: 08 9329 3396

info@argenica.com.au

Home
About
Investors
Media
- News & Media
- Presentations
Contact Us

The Science
Development

© Copyright 2025 Argenica Therapeutics Pty Ltd Privacy Policy Terms & Conditions

Website by Crux Creative and Meta Creative

Home
About
Investors
Technology
Media
- News & Media
Contact

Privacy Policy
Terms & Conditions